Tetrodotoxin-induced involuntary movements: a case report

Background: Tetrodotoxin (TTX) is a potent neurotoxin found in pufferfish that blocks voltage-gated sodium channels and leads to flaccid paralysis. Although its effects are typically limited to the peripheral nervous system, rare central neurological manifestations may be under-recognized. Case: A 70-year-old male presented to the emergency department approximately 10 h after consuming pufferfish stew. The initial symptoms included slurred speech, facial weakness, and general fatigue without respiratory compromise. Vital signs and laboratory evaluations, including cardiac enzyme levels, blood gas analysis, and toxicology screening, were within normal limits. Brain computed tomography and electrocardiogramrevealed no acute abnormalities. Shortly after arrival, the patient developed progressive involuntary side-to-side head movements and repetitive swaying of the upper body. Comprehensive toxicological screening revealed negative results for other neurotoxins. Supportive care was administered and no antidotes were available. Over the course of 12 to 24 h, the involuntary movements gradually subsided and fully resolved by 48 h post-ingestion, with complete neurological recovery. Conclusion: This case report describes a rare presentation of tetrodotoxin poisoning involving involuntary motor activity, suggesting potential central nervous system involvement. This challenges the conventional understanding that tetrodotoxin toxicity is confined to the peripheral nervous system. Clinicians should be aware of such atypical features to ensure a timely diagnosis and appropriate supportive care.

Tetrodotoxin; Nervous system diseases; Poisoning; Involuntary movements

[1] Al-Sulaimani S, Titelbaum NV, Ward RE, Zahran TE, Chalhoub S, Kazzi Z. Case report of tetrodotoxin poisoning from Lagocephalus sceleratus in Lebanon. International Journal of Environmental Research and Public Health. 2022; 19: 14648.

[2] Isbister GK, Kiernan MC. Neurotoxic marine poisoning. The Lancet Neurology. 2005; 4: 219–228.

[3] Lago J, Rodríguez LP, Blanco L, Vieites JM, Cabado AG. Tetrodotoxin, an extremely potent marine neurotoxin: distribution, toxicity, origin and therapeutical uses. Marine Drugs. 2015; 13: 6384–6406.

[4] Bane V, Lehane M, Dikshit M, O’Riordan A, Furey A. Tetrodotoxin: chemistry, toxicity, source, distribution and detection. Toxins. 2014; 21: 693–755.

[5] Noguchi T, Arakawa O. Tetrodotoxin—distribution and accumulation in aquatic organisms, and cases of human intoxication. Marine Drugs. 2008; 6: 220–242.

[6] Katikou P, Gokbulut C, Kosker AR, Campàs M, Ozogul F. An updated review of tetrodotoxin and its peculiarities. Marine Drugs. 2022; 20: 47.

[7] Hwang DF, Noguchi T. Tetrodotoxin poisoning. Advances in Food and Nutrition Research. 2007; 52: 141–236.

[8] How CK, Chern CH, Huang YC, Wang LM, Lee CH. Tetrodotoxin poisoning. The American Journal of Emergency Medicine. 2003; 21: 51–54.

[9] Mi W, Liu S. Tetrodotoxin and the state-of-the-art progress of its associated analytical methods. Frontiers in Microbiology. 2024; 15: 1413741.

[10] Varini C, Manganelli M, Scardala S, Antonelli P, Losasso C, Testai E. An update of tetrodotoxins toxicity and risk assessment associated to contaminated seafood consumption in Europe: a systematic review. Toxins. 2025; 17: 76.

[11] Zhang X, Qiao K, Cui R, Xu M, Cai S, Huang Q, et al. Tetrodotoxin: the state-of-the-art progress in characterization, detection, biosynthesis, and transport enrichment. Marine Drugs. 2024; 22: 531.

[12] O’Leary MA, Schneider JJ, Isbister GK. Use of high performance liquid chromatography to measure tetrodotoxin in serum and urine of poisoned patients. Toxicon. 2004; 44: 549–553.

[13] Kheifets J, Rozhavsky B, Girsh Solomonovich Z, Marianna R, Soroksky A. Severe tetrodotoxin poisoning after consumption of Lagocephalus sceleratus (Pufferfish, Fugu) Fished in Mediterranean Sea, treated with cholinesterase inhibitor. Case Reports in Critical Care. 2012; 2012: 782507.

[14] Al Homsi A, Hassan N, Hamad I, Qasem R. A case of puffer fish poisoning from United Arab Emirates. Oman Medical Journal. 2023; 38: e510.

[15] Liu Z, Wang Z, Wei Y, Shi J, Shi T, Chen X, et al. Transcriptomic profiling of tetrodotoxin-induced neurotoxicity in human cerebral organoids. Marine Drugs. 2023; 21: 588.

[16] Yao J, Jin Z, Zhao Y. Electroactive and SERS-Active Ag@Cu2O NP-programed aptasensor for dual-mode detection of tetrodotoxin. ACS Applied Materials & Interfaces. 2023; 15: 10240–10249.

[17] Narahashi T. Mechanism of action of tetrodotoxin and saxitoxin on excitable membranes. Federation Proceedings. 1972; 31: 1124–1132.

[18] Kotipoyina HR, Kong EL, Chen RJ, Warrington SJ. Tetrodotoxin toxicity. StatPearls Publishing: Treasure Island (FL). 2023.

[19] Vlamis A, Katikou P, Rodriguez I, Rey V, Alfonso A, Papazachariou A, et al. First detection of tetrodotoxin in Greek shellfish by UPLC-MS/MS potentially linked to the presence of the dinoflagellate prorocentrum minimum. Toxins. 2015; 7: 1779–1807.

[20] Melnikova DI, Khotimchenko YS, Magarlamov TY. Addressing the issue of tetrodotoxin targeting. Marine Drugs. 2018; 16: 352.

[21] Fetsko AR, Sebo DJ, Budzynski LB, Scharbarth A, Taylor MR. IL-1β disrupts the initiation of blood-brain barrier development by inhibiting endothelial Wnt/β-catenin signaling. iScience. 2024; 27: 109651.

[22] Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. Journal of Neuroinflammation. 2015; 12: 223.

[23] Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain, Behavior, and Immunity. 2017; 60: 1–12.

[24] Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neuroscience & Therapeutics. 2021; 27: 36–47.

[25] Yang J, Ran M, Li H, Lin Y, Ma K, Yang Y, et al. New insight into neurological degeneration: inflammatory cytokines and blood-brain barrier. Frontiers in Molecular Neuroscience. 2022; 15: 1013933.

[26] Wardill HR, Mander KA, Van Sebille YZ, Gibson RJ, Logan RM, Bowen JM, et al. Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. International Journal of Cancer. 2016; 139: 2635–2645.